News & Analysis as of

Initial Public Offering (IPO) Private Equity Acquisitions

Skadden, Arps, Slate, Meagher & Flom LLP

US Capital Markets Midyear Report: The Revival of IPOs and a Possible Turning Point

As a testament to the U.S. capital markets’ resilience and ability to adapt, IPOs, debt markets and mergers and acquisitions (and related financings) have shown substantial increases over 2023. Activity to date in 2024...more

Skadden, Arps, Slate, Meagher & Flom LLP

Challenging Exit and Debt Conditions Prompt Financial Sponsors To Adopt Workarounds

The challenges facing financial sponsors in the past couple of years have been widely discussed. Their funds have amassed over $1 trillion in dry powder that they are competing to deploy in a weak exit market....more

White & Case LLP

Japan’s PE market is thriving, with potential for exits to follow

White & Case LLP on

Stronger stock market performance bodes well for exit conditions in Japan’s rapidly maturing PE space - Interested observers have long anticipated the “arrival” of Japan’s private equity market. As the world’s...more

McDermott Will & Emery

Dual Track Reboot: Five Key Considerations for Supercharging Your Life Science Company Exit

McDermott Will & Emery on

There have been 44 initial public offerings (IPOs) listed on the US stock markets in 2024 thus far, many of which continue to trade at a premium to their initial offering price, demonstrating the strength and buoyancy of...more

Ballard Spahr LLP

Key Takeaways From the 2024 J.P. Morgan Healthcare Conference

Ballard Spahr LLP on

Ballard Spahr attorneys from the firm’s Life Sciences and Health Care Industry Teams were on the ground for the 42nd Annual J.P. Morgan Healthcare Conference (JPM24) from January 7-10. While still less crowded than...more

A&O Shearman

Embracing legal tech: A game-changer for IPO success

A&O Shearman on

This tech-driven approach is not just an option; it's a necessity. Michael Bloch, Partner at A&O, explains, "IPOs are incredibly complex, but we are exploring ways to make them less painful for everyone involved through the...more

White & Case LLP

Sector trends - September 2023: Stock Exchanges/Clearing Houses/Trading Venues

White & Case LLP on

Decisive inorganic growth decisions by London Stock Exchange, Deutsche Börse, Nasdaq and Euronext set a furious pace for European trading venue M&A activity....more

Lippes Mathias LLP

Venture Capital 101

Lippes Mathias LLP on

A company starts off with an idea and needs capital to secure a patent and build a prototype .At this point, the founding team’s personal resources and network are the primary source of capital. ...more

White & Case LLP

M&A holds the line in the Nordics with robust performance

White & Case LLP on

Corporate deals in the region proved to be more resilient than private equity (PE) as financing costs rose, with exits showing weakness - M&A market activity in the Nordics (Sweden, Denmark, Norway, Finland and Iceland)...more

Foley & Lardner LLP

Will We See the Predicted M&A Spike in 2023?

Foley & Lardner LLP on

In 2022, many predicted we would see a spike in M&A due to the economic downturn and the steep drop in startup valuations. However, last year was not the M&A blockbuster that was predicted, and we even saw a drop-off in...more

Orrick, Herrington & Sutcliffe LLP

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2022

This edition of Orrick’s life sciences publication series breaks down the key drivers of venture investment in the life sciences industry during Q1 2022, which saw some disruptions following a record year in 2021. Key...more

Goodwin

European Life Sciences Deals Trends

Goodwin on

In Europe, life sciences deals increased over the last few years with strong acceleration in 2021. As a result, the market wonders whether this is just an uptick or rather a steady trend which will impact our market in the...more

White & Case LLP

Pharma and healthcare deliver strong results

White & Case LLP on

Despite the absence of megadeals, M&A in the sector climbed from 2020 levels thanks in part to strong PE and SPAC activity - Healthcare and pharmaceutical deals continued at a robust pace through 2021, registering the...more

Morrison & Foerster LLP

M&A in 2021 and Trends for 2022

2021 M&A smashed U.S. and global records. The year saw the arrival of a new U.S. administration, the release of COVID-19 vaccines, as well as continued questions regarding the impact of the pandemic, including the year-end...more

Orrick, Herrington & Sutcliffe LLP

OLNS#9: Venture Capital Deals in Germany – Pitfalls, Key Terms and Success Factors Founders Need to Know

In substantially all the major world markets, we have dedicated technology lawyers who support young German technology companies on their growth trajectory through all stages. As one of the top tech law firms in the world, we...more

Sheppard Mullin Richter & Hampton LLP

Trends in Digital Health Funding and Transactions: A Tremendous Year So Far

As the world continues to shift and adapt to the ongoing COVID-19 pandemic, the digital health sector has experienced tremendous growth and the momentum has only accelerated in 2021. According to the Digital Health...more

White & Case LLP

Financial institutions M&A: Payments

White & Case LLP on

Financial institutions M&A sector trends: payments — H1 2021 and outlook for H2 2021 - The COVID-19 pandemic drove e-commerce to levels never seen before—payment rail, service and solution providers responded with an...more

Latham & Watkins LLP

Europe Set for Increased SPAC Activity

Latham & Watkins LLP on

As interest in European SPACs heats up amid an increasingly receptive regulatory environment, dealmakers must navigate market differences. While US special purpose acquisition company (SPAC) IPOs and related M&A activity...more

Farella Braun + Martel LLP

Turmoil in the SPAC Market: What Private Tech Companies Should Consider Before Going Public Via a SPAC

In the spring of 2021, one of the hottest markets—the market for special purpose acquisition companies, or SPACs—has “screeched to a halt,” according to CNN. As the SPAC market grew red hot in the past six months, it seemed...more

K&L Gates LLP

To SPAC or Not to SPAC – Key Considerations for Mid-Sized Private Equity Managers

K&L Gates LLP on

SPAC initial public offerings (IPOs) were all the rage in 2020, and they have picked up even more steam in 2021—reaching new heights. Private equity sponsors have emerged as key players in the SPAC sponsorship space, and...more

White & Case LLP

US SPACs look beyond their backyard to Europe

White & Case LLP on

Although most SPAC activity is concentrated in the US, the boom in listings spells opportunities for European firms - Amid the ups and downs in financial markets in 2020, the boom in activity in the special purpose...more

Opportune LLP

SPACs Are All The Rage, But Acquisition Concerns Loom

Opportune LLP on

SPACs, or so-called “blank check companies”, are an alternative and expedient route to going public, but the financial reporting, tax, and governance aspects of the SPAC’s future investments must be considered. Previously...more

Allen Matkins

PropTech Update - November 2020

Allen Matkins on

Tishman Speyer forms $300 million SPAC to invest in PropTech companies - Bullet The Real Deal – October 26 - Tishman Speyer has formed a $300 million blank-check company — becoming the first major real estate owner to...more

McDermott Will & Emery

[Webinar] Are SPACs Right for Your Business? A Fireside Chat with SPAC Trailblazers DraftKings and Chardan Capital Markets -...

McDermott Will & Emery on

With 169 special purpose acquisition company (SPAC) initial public offerings (IPOs) and 102 SPAC mergers and counting this year, SPACs are hotter than ever. But are they right approach for your portfolio companies seeking...more

McDermott Will & Emery

[Webinar] The Explosion of SPACs – What Private Equity Wants to Know - August 6th, 1:30 pm - 2:15 pm EDT

McDermott Will & Emery on

The interest in special purpose acquisition company (SPAC) transactions continues to skyrocket, with nearly half of all IPOs year-to-date filed by SPACs and with “de-SPAC” transactions increasing. Join McDermott on...more

34 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide